Roche’s Spark Therapeutics unit is pitching $575 million into a new gene therapy manufacturing facility at Drexel University’s Philadelphia campus that will work towards the next generation of genetic…
After a summer of deals, Ipsen is closing out the year with one last hurrah. The rare-disease-focused biopharma will partner with Genfit on a liver disease drug in a tie-up potentially worth a half…
The ILR ECG Analyzer algorithm sifts through collected heart rhythm data to spot instances of atrial fibrillation and other arrhythmias with what Implicity says is greater accuracy than ICMs alone.
V-Wave has raised $98 million to complete the clinical testing of its implant for severe heart failure and pulmonary arterial hypertension, as well as set up the device for FDA review.
Cultural resilience aims to institutionalize aspects of a business culture distinguished for how mental health is valued and understand the inextricable link between mental wellbeing and productivity. Mike Nolte is the CEO of Uprise Health , a leading digital mental health company that cares for the total person. Our Sites © 2021 Breaking Media, Inc. …
The insurers referred to deals Gilead struck with Janssen, Bristol Myers Squibb to prevent the generic version of its retroviral medications from being used as part of combination treatments. They…
MedCity Influencers Digital health’s ‘wow factor’ should focus on the patient
Abbott CEO and President Robert Ford becomes chair of the board as two-decade leader Miles White retires. Gritstone’s chief medical officer leaves to helm the same post at Neogene Therapeutics. Former…
We cannot simply accept that testing new drugs will continue to be a slow and expensive process. AI has the potential to disrupt the current approach to clinical trials — from patient recruitment to…
Ipsen is paying €120 million up front to acquire global rights to elafibranor, a Genfit drug that fell short as a treatment for NASH, but is currently in Phase 3 testing in another liver disease,…
